PACT is a privately held immuno-oncology company dedicated to engineering T cell therapies by seeking to harness the inherent biology and curative potential of each patient's immune system to treat their cancer and advance the field of immune-driven medicines.
Mission & Vision
Our
Platform
Our
Programs